Public Release: 18-Oct-2016
Supplement lowers testosterone levels in women with common cause of infertility
The Endocrine Society
Washington, DC–Resveratrol–a natural compound found in red wine and grapes–can help address a hormone imbalance in women with polycystic ovary syndrome (PCOS), a leading cause of infertility in women, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
An estimated 5 million to 6 million women in the United States have PCOS, according to the Hormone Health Network. It is one of the most common endocrine conditions in women of childbearing age.
Women who have PCOS produce slightly higher amounts of testosterone and other androgen hormones than average. Although these reproductive hormones are typically associated with men, women also have small amounts. The elevated levels in women with PCOS can contribute to irregular or absent menstrual periods, infertility, weight gain, acne or excess hair on the face and body. Women who have PCOS also face a higher risk of developing other health problems, such as diabetes.
Resveratrol is one of a group of plant compounds known as polyphenols. In addition to red wine and grapes, resveratrol is found in nuts. The compound has anti-inflammatory properties.
“Our study is the first clinical trial to find resveratrol significantly lowers PCOS patients’ levels of testosterone as well as dehydroepiandrosterone sulfate (DHEAS), another hormone that the body can convert into testosterone,” said the study’s senior author, Antoni J. Duleba, MD, of the University of California, San Diego in La Jolla, CA. “This nutritional supplement can help moderate the hormone imbalance that is one of the central features of PCOS.”
Thirty women with PCOS completed the randomized, double-blind, placebo-controlled trial conducted at Poznan University of Medical Sciences in Poznan, Poland. The women were randomly assigned to either take a resveratrol supplement or a placebo pill daily for three months. The participants had blood samples drawn at the beginning and end of the study to determine levels of testosterone and other androgen hormones. The women also underwent an oral glucose tolerance test at the start and conclusion of the study to measure diabetes risk factors.
The researchers found total testosterone levels fell by 23.1 percent among the women who received the resveratrol supplement. In comparison, testosterone levels increased 2.9 percent in the placebo group. DHEAS declined by 22.2 percent in the resveratrol group, while the placebo group experienced a 10.5 percent increase in DHEAS levels.
In addition to moderating androgen hormones, the women who received resveratrol showed improvement in diabetes risk factors. Among the resveratrol group, fasting insulin levels dropped by 31.8 percent during the three-month study. The researchers also found the women who received resveratrol during the study became more responsive to the hormone insulin over the course of the study.
“The findings suggest resveratrol can improve the body’s ability to use insulin and potentially lower the risk of developing diabetes,” Duleba said. “The supplement may be able to help reduce the risk of metabolic problems common in women with PCOS.”
The study, “Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial,” will be published online at http://press.endocrine.org/doi/10.1210/jc.2016-1858, ahead of print.
Other authors of the study include: Beata Banaszewska, Joanna Wroty?ska-Barczy?ska, Robert Z. Spaczynski and Leszek Pawelczyk of Poznan University of Medical Sciences in Poznan, Poland.
RevGenetics provided the resveratrol for the study.
For more information on PCOS, visit the Hormone Health Network’s digital toolkit.
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society, which is celebrating its centennial in 2016, has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.